These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

496 related items for PubMed ID: 2572437

  • 1. Effects of sulfasalazine and a sulfasalazine analogue on the formation of lipoxygenase and cyclooxygenase products.
    Tornhamre S, Edenius C, Smedegård G, Sjöquist B, Lindgren JA.
    Eur J Pharmacol; 1989 Oct 10; 169(2-3):225-34. PubMed ID: 2572437
    [Abstract] [Full Text] [Related]

  • 2. Inhibition of platelet thromboxane synthetase by sulfasalazine.
    Stenson WF, Lobos E.
    Biochem Pharmacol; 1983 Jul 15; 32(14):2205-9. PubMed ID: 6135423
    [Abstract] [Full Text] [Related]

  • 3. Modulation of human colonic arachidonic acid metabolism by sulfasalazine.
    Hawkey CJ, Boughton-Smith NK, Whittle BJ.
    Dig Dis Sci; 1985 Dec 15; 30(12):1161-5. PubMed ID: 2866075
    [Abstract] [Full Text] [Related]

  • 4. A comparison of effects of sulfasalazine and its metabolites on the metabolism of endogenous vs. exogenous arachidonic acid.
    Allgayer H, Stenson WF.
    Immunopharmacology; 1988 Dec 15; 15(1):39-46. PubMed ID: 2896181
    [Abstract] [Full Text] [Related]

  • 5. Effect of indomethacin on arachidonic acid metabolism in human leukocytes stimulated ex vivo.
    Docherty JC, Wilson TW.
    Clin Pharmacol Ther; 1991 Mar 15; 49(3):294-9. PubMed ID: 1848800
    [Abstract] [Full Text] [Related]

  • 6. Inhibition of leukotriene formation in human leukocytes by halothane.
    Yamaoka A, Sumimoto H, Takeshige K, Itoh T, Isobe R, Yoshitake J, Minakami S.
    Biochim Biophys Acta; 1987 Apr 24; 918(3):284-92. PubMed ID: 3032266
    [Abstract] [Full Text] [Related]

  • 7. Characteristics of leukotriene (LT) and hydroxy eicosatetraenoic acid (HETE) synthesis in human leukocytes in vitro: effect of arachidonic acid concentration.
    Fruteau de Laclos B, Braquet P, Borgeat P.
    Prostaglandins Leukot Med; 1984 Jan 24; 13(1):47-52. PubMed ID: 6324240
    [Abstract] [Full Text] [Related]

  • 8. Lipoxygenase pathways of macrophages.
    Bonney RJ, Opas EE, Humes JL.
    Fed Proc; 1985 Nov 24; 44(14):2933-6. PubMed ID: 2996948
    [Abstract] [Full Text] [Related]

  • 9. Sulfasalazine and 5-aminosalicylic acid inhibit contractile leukotriene formation.
    Nielsen ST, Beninati L, Buonato CB.
    Scand J Gastroenterol; 1988 Apr 24; 23(3):272-6. PubMed ID: 2898806
    [Abstract] [Full Text] [Related]

  • 10. In vitro effects of E3040, a dual inhibitor of 5-lipoxygenase and thromboxane A(2) synthetase, on eicosanoid production.
    Oketani K, Nagakura N, Harada K, Inoue T.
    Eur J Pharmacol; 2001 Jun 22; 422(1-3):209-16. PubMed ID: 11430933
    [Abstract] [Full Text] [Related]

  • 11. Effects of exogenous arachidonic, eicosapentaenoic, and docosahexaenoic acids on the generation of 5-lipoxygenase pathway products by ionophore-activated human neutrophils.
    Lee TH, Mencia-Huerta JM, Shih C, Corey EJ, Lewis RA, Austen KF.
    J Clin Invest; 1984 Dec 22; 74(6):1922-33. PubMed ID: 6096400
    [Abstract] [Full Text] [Related]

  • 12. Characterization of CGS 8515 as a selective 5-lipoxygenase inhibitor using in vitro and in vivo models.
    Ku EC, Raychaudhuri A, Ghai G, Kimble EF, Lee WH, Colombo C, Dotson R, Oglesby TD, Wasley JW.
    Biochim Biophys Acta; 1988 Apr 15; 959(3):332-42. PubMed ID: 2833314
    [Abstract] [Full Text] [Related]

  • 13. High-performance liquid chromatographic quantitation of cyclooxygenase and lipoxygenase metabolites of arachidonic acid from rat polymorphonuclear leukocytes.
    Tordjman C, Serkiz B, Rambaud F, Bonnet J, Volland JP.
    J Chromatogr; 1990 Oct 26; 532(1):135-43. PubMed ID: 1964162
    [No Abstract] [Full Text] [Related]

  • 14. Intracellular retention of the 5-lipoxygenase pathway product, leukotriene B4, by human neutrophils activated with unopsonized zymosan.
    Williams JD, Lee TH, Lewis RA, Austen F.
    J Immunol; 1985 Apr 26; 134(4):2624-30. PubMed ID: 2982947
    [Abstract] [Full Text] [Related]

  • 15. Inhibition of 5-lipoxygenase pathway of arachidonic acid metabolism in human neutrophils by sulfasalazine and 5-aminosalicylic acid.
    Nielsen OH, Bukhave K, Elmgreen J, Ahnfelt-Rønne I.
    Dig Dis Sci; 1987 Jun 26; 32(6):577-82. PubMed ID: 2882965
    [Abstract] [Full Text] [Related]

  • 16. Inhibition of ionophore-stimulated leukotriene B4 production in human leucocytes by monohydroxy fatty acids.
    Camp RD, Fincham NJ.
    Br J Pharmacol; 1985 Aug 26; 85(4):837-41. PubMed ID: 2994785
    [Abstract] [Full Text] [Related]

  • 17. Modulation of alveolar macrophage-derived 5-lipoxygenase products by the sulfhydryl reactant, N-ethylmaleimide.
    Peters-Golden M, Shelly C.
    J Biol Chem; 1987 Aug 05; 262(22):10594-600. PubMed ID: 3112148
    [Abstract] [Full Text] [Related]

  • 18. 1-[4-[3-[4-[bis(4-fluorophenyl)hydroxymethyl]-1- piperidinyl]propoxy]-3-methoxyphenyl]ethanone(AHR-5333): a selective human blood neutrophil 5-lipoxygenase inhibitor.
    Graff G, Anderson LA.
    Prostaglandins; 1989 Oct 05; 38(4):473-96. PubMed ID: 2554366
    [Abstract] [Full Text] [Related]

  • 19. Ebselen reduces the formation of LTB4 in human and porcine leukocytes by isomerisation to its 5S, 12R-6-trans-isomer.
    Kuhl P, Borbe HO, Fischer H, Römer A, Safayhi H.
    Prostaglandins; 1986 Jun 05; 31(6):1029-48. PubMed ID: 3020614
    [Abstract] [Full Text] [Related]

  • 20. Detection of a novel cyclooxygenase metabolite produced by human promyelocytic leukemia (HL-60) cells.
    Agins AP, Hollmann AB, Agarwal KC, Wiemann MC.
    Biochem Biophys Res Commun; 1985 Jan 16; 126(1):143-9. PubMed ID: 2982366
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.